pica pica melanotos / Black-billed magpie in Parque biológico de Gaia Magpie (Pica pica) Flying at

Key Safety Differentiators No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy

Clinically proven to improve skin texture, dark circles, and fine lines within two weeks of use,

These signs often go hand in hand with underlying gut conditions that block proper cobalamin absorption

For short-term storage (a few weeks), a refrigerator is also acceptable